Literature DB >> 20938042

Genetic causes of frontotemporal degeneration.

Tricia M See1, Amanda K LaMarre, Suzee E Lee, Bruce L Miller.   

Abstract

The purpose of this review is to provide a comprehensive update on the genetic causes of frontotemporal lobar degeneration (FTLD). Approximately 40% to 50% of patients diagnosed with FTLD have a family history of a ''related disorder,'' whereas 10% to 40% have an autosomal dominant family history for the disease. At this time, mutations occurring in 2 independent genes located on the same chromosome (MAPT and GRN) have been shown to cause the majority of cases of autosomal dominant FTLD. Specific genetic, molecular, pathological, and phenotypic variations associated with each of these gene mutations are discussed, as well as markers that may help differentiate the 2. In addition, 3 relatively rare, additional genes known to cause familial FTLD are examined in brief. Lastly, genetic counseling issues which may be important to the community clinician are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20938042     DOI: 10.1177/0891988710383574

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  11 in total

1.  Clinical and genetic analyses of familial and sporadic frontotemporal dementia patients in Southern Italy.

Authors:  Rosa Capozzo; Celeste Sassi; Monia B Hammer; Simona Arcuti; Chiara Zecca; Maria R Barulli; Rosanna Tortelli; J Raphael Gibbs; Cynthia Crews; Davide Seripa; Francesco Carnicella; Claudia Dell'Aquila; Marco Rossi; Filippo Tamma; Francesco Valluzzi; Bruno Brancasi; Francesco Panza; Andrew B Singleton; Giancarlo Logroscino
Journal:  Alzheimers Dement       Date:  2017-03-03       Impact factor: 21.566

2.  Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.

Authors:  Ging-Yuek R Hsiung; Mariely DeJesus-Hernandez; Howard H Feldman; Pheth Sengdy; Phoenix Bouchard-Kerr; Emily Dwosh; Rachel Butler; Bonnie Leung; Alice Fok; Nicola J Rutherford; Matt Baker; Rosa Rademakers; Ian R A Mackenzie
Journal:  Brain       Date:  2012-02-17       Impact factor: 13.501

3.  Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers.

Authors:  Carolina Alquézar; Ana de la Encarnación; Fermín Moreno; Adolfo López de Munain; Ángeles Martín-Requero
Journal:  J Psychiatry Neurosci       Date:  2016-06       Impact factor: 6.186

4.  Distinct TDP-43 pathology in ALS patients with ataxin 2 intermediate-length polyQ expansions.

Authors:  Michael P Hart; Johannes Brettschneider; Virginia M Y Lee; John Q Trojanowski; Aaron D Gitler
Journal:  Acta Neuropathol       Date:  2012-04-21       Impact factor: 17.088

5.  Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.

Authors:  Monica Javidnia; Michaeline L Hebron; Yue Xin; Nikolas G Kinney; Charbel E-H Moussa
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

6.  Rare variants in the neuronal ceroid lipofuscinosis gene MFSD8 are candidate risk factors for frontotemporal dementia.

Authors:  Ethan G Geier; Mathieu Bourdenx; Nadia J Storm; J Nicholas Cochran; Daniel W Sirkis; Ji-Hye Hwang; Luke W Bonham; Eliana Marisa Ramos; Antonio Diaz; Victoria Van Berlo; Deepika Dokuru; Alissa L Nana; Anna Karydas; Maureen E Balestra; Yadong Huang; Silvia P Russo; Salvatore Spina; Lea T Grinberg; William W Seeley; Richard M Myers; Bruce L Miller; Giovanni Coppola; Suzee E Lee; Ana Maria Cuervo; Jennifer S Yokoyama
Journal:  Acta Neuropathol       Date:  2018-10-31       Impact factor: 17.088

7.  Hormone replacement therapy and risk for neurodegenerative diseases.

Authors:  Richelin V Dye; Karen J Miller; Elyse J Singer; Andrew J Levine
Journal:  Int J Alzheimers Dis       Date:  2012-04-04

8.  Tau deletion impairs intracellular β-amyloid-42 clearance and leads to more extracellular plaque deposition in gene transfer models.

Authors:  Irina Lonskaya; Michaeline Hebron; Wenqiang Chen; Joel Schachter; Charbel Moussa
Journal:  Mol Neurodegener       Date:  2014-11-10       Impact factor: 14.195

9.  Intrafamilial Phenotypic Variability in the C9orf72 Gene Expansion: 2 Case Studies.

Authors:  David Foxe; Elle Elan; James R Burrell; Felicity V C Leslie; Emma Devenney; John B Kwok; Glenda M Halliday; John R Hodges; Olivier Piguet
Journal:  Front Psychol       Date:  2018-09-03

10.  Cerebrospinal fluid biomarkers and cognitive status in differential diagnosis of frontotemporal dementia and Alzheimer's disease.

Authors:  Tiziana Casoli; Susy Paolini; Paolo Fabbietti; Patrizia Fattoretti; Lucia Paciaroni; Katia Fabi; Beatrice Gobbi; Roberta Galeazzi; Roberto Rossi; Fabrizia Lattanzio; Giuseppe Pelliccioni
Journal:  J Int Med Res       Date:  2019-09-16       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.